beat · 12 stories
Hospitals spent two years building their own AI medical-record tools; now they're consolidating on Epic, the dominant U.S. electronic-health-records platform.
The White House deputy behind RFK Jr.'s 'Make America Healthy Again' (MAHA) agenda's early moves is up for the agency that signs off on every shot and pill. Her conflicts list is the first thing to read.
An investigator-initiated trial puts the medical institution on the hook before the company. A 12-month silence shows what that rule looks like without teeth.
In one year, Merck and Moderna's personalized mRNA vaccine and Revolution Medicines' pill targeting a hard-to-drug cancer gene (KRAS G12D) both posted late-stage trial wins. One analyst calls that rare.
Harvard has kept organoids, microscopic clumps of human brain cells, alive for more than five years, the longest such cultures on record, and found they aged on a human developmental schedule.
The placental receptor FcRn (the neonatal Fc receptor) carries protective IgG antibodies across to the fetus but largely excludes albumin — a sorting asymmetry drug designers can exploit by fusing antibody medicines to the long-lived blood protein,
An investigational drug halts the malaria parasite in the liver before it can reach the blood and cause disease, turning each mosquito-delivered parasite into an immune-training event and sparing mice from illness.
In a 268-patient European randomized trial of the Whipple procedure — a complex pancreatic-cancer operation — the robotic approach had a small quality-of-life deficit and less than a 30% chance of being cost-effective.
Oligonucleotide drugs are short, synthetic DNA or RNA strands that act upstream of proteins. A $7.5M grant for an ALS program shows the class now reaching targets pills cannot hit.
A systematic review of 15 studies finds one digital pathology platform already validated across 12 centers, but most AI models still lack the testing needed for clinic.
A Wiley study worked around the yeast's own protein-chopping enzymes to produce a continuous 585-amino-acid fragment of type III collagen, but the product does not form the triple helix of the native protein.
Nine AI architectures trained on 4,307 rat histology slides scored near-perfect on internal tests.